Pinetree Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Pinetree Therapeutics, Inc. - overview
Established
2019
Location
Cambridge, MA, US
Primary Industry
Biotechnology
About
Founded in 2019 and based in Massachusetts, US, Pinetree Therapeutics, Inc. operates as a preclinical stage biotechnology company that uses TAER-TAB technology, a bispecific antibody (bsAb) that targets cancer cells in the lungs, breasts, pancreas, cervix, colon, kidneys, ovaries, stomach, and others. In October 2025, Pinetree Therapeutics, Inc. raised USD 47 million in series B funding from returning investors DSC Investment, WIDWIN Investment, STIC Ventures, Samho Green Investment, Atinum Investment, S&S Investment, SJ Investment Partners, Smilegate Investment, and Gauss Capital Management, with participation from individual and other unspecified investors.
The company's therapeutical services are based on technology TAER-TAB (Tumour Associated Essential Receptor Targeting Antibody), a platform technology that can be used to create multifunctional antibodies directed against multiple receptor targets on cancer cells, and ViTRAP (Virus Targeting Recombinant Agent Platform), an antiviral technology which can design discrete, disease-specific, biologic therapeutics for many diseases with unmet needs on a global basis. The company will use the funding to advance research, develop new products, and support collaborations.
Current Investors
InterVest, DSC Investment, Samho Green Investment
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.pinetreetx.com
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.